Pharmaceuticals North America

North America Menopause Treatment Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

North America Menopause Treatment Market Industry Trends and Forecast to 2034: Segmented by (Treatment, Symptom, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

North America · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $8.13 Bn Placeholder estimate
Estimate 2025 $8.49 Bn 46.2% of the global market
Projected 2034 $12.51 Bn 47.3% Adds $4.02 Bn over 9 forecast years
CAGR 2025–2034 4.4% Faster than 19% of 180 Pharmaceuticals markets here
Key players 6 +1
  • North America is 46.24% of the global market.
  • Among regions, the largest is North America (this report) at $8.49 Bn.
  • Fastest growing: APAC at 7% a year.
  • North America ranks 1st of 6 by size among regions.

Market size projection

North America

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$4.02 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Menopause Treatment Market market size by year, North America
YearMarket sizeChange that yearSince 2025
2024 (estimate) $8.13 Bn — —
2025 (base) $8.49 Bn +$357.9 Mn —
2026 (forecast) $8.87 Bn +$373.6 Mn +4.4%
2027 (forecast) $9.26 Bn +$390.1 Mn +9%
2028 (forecast) $9.66 Bn +$407.2 Mn +13.8%
2029 (forecast) $10.09 Bn +$425.2 Mn +18.8%
2030 (forecast) $10.53 Bn +$443.9 Mn +24%
2031 (forecast) $10.99 Bn +$463.4 Mn +29.5%
2032 (forecast) $11.48 Bn +$483.8 Mn +35.2%
2033 (forecast) $11.98 Bn +$505.1 Mn +41.1%
2034 (forecast) $12.51 Bn +$527.3 Mn +47.3%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

North America Menopause Treatment Market Analysis at a glance
Market size, 2025$8.49 Bn placeholder estimate
Forecast, 2034$12.51 Bn placeholder estimate
Growth (CAGR), 2025–20344.4% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTreatment, symptom and end user (see all)
Key playersAstellas Pharma Inc., Bayer AG, Pfizer Inc., Novo Nordisk A/S, TherapeuticsMD and 1 more (see all)
Active clinical trials131 in North AmericaSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in North America. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The North America Menopause Treatment Market Analysis Executive Summary

Menopause treatment relieves symptoms such as hot flashes, sleep problems and bone loss with hormone therapy, non-hormonal medicines and supplements.

Key segments of the menopause Treatment market include treatment (Hormone Replacement Therapy, Non-Hormonal Drugs and NK3 Receptor Antagonists) and symptom (Vasomotor Symptoms, Vaginal Atrophy and Osteoporosis).

Bar chart: North America Menopause Treatment market size, 2024–2034, placeholder estimates. $8.13 Bn in 2024, $8.49 Bn in 2025 and $12.51 Bn in 2034, 4.4% CAGR.
North America Menopause Treatment market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

North America Menopause Treatment Market Dynamics

Market Growth Drivers

Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the menopause Treatment market. New products designed around women's biology and digital care are improving access.

Opportunity

Femtech, personalised care and new treatments for under-served conditions open strong growth for the menopause Treatment market, especially as employers and payers add women's health benefits.

Market Restraints

Under-diagnosis, stigma around some conditions, limited insurance coverage and a long history of under-research in women's health hold back the menopause Treatment market.

Competitive Landscape for Menopause Treatment Market in North America

The menopause Treatment market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Menopause Treatment Market in North America

Menopause Treatment in North America: rules, payment and research

In the countries we cover here, medicines are approved by Health Canada (Canada)⁠[1] and FDA (US)⁠[2]. How care is paid for in these countries: provincial health insurance (Canada)⁠[3] and Medicare and Medicaid (US)⁠[4]. ClinicalTrials.gov lists 131 studies on Menopause Treatment that are recruiting, active or about to start in North America.⁠[5]

[1] Health Canada. Checked 14 Nov 2026.

[2] US Food and Drug Administration. Checked 14 Nov 2026.

[3] Health Canada. Checked 14 Nov 2026.

[4] Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.

[5] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in North America. Retrieved 12 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for menopause Treatment. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in North America.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Menopause Treatment right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Menopause Treatment in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Menopause Treatment market in North America?
Placeholder estimate: about $8.49 Bn in 2025, rising to about $12.51 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Menopause Treatment market in North America growing?
Placeholder estimate: about 4.4% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Menopause Treatment market report cover?
The report splits the market by treatment (Hormone Replacement Therapy, Non-Hormonal Drugs, NK3 Receptor Antagonists, Supplements), symptom (Vasomotor Symptoms, Vaginal Atrophy, Osteoporosis, Sleep and Mood) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the Menopause Treatment market?
Key players include Astellas Pharma Inc., Bayer AG, Pfizer Inc., Novo Nordisk A/S, TherapeuticsMD and Mithra Pharmaceuticals.
What is driving the Menopause Treatment market?
Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the menopause Treatment market. New products designed around women's biology and digital care are improving access.
How many clinical trials on Menopause Treatment are running in North America?
131 studies are recruiting, active or about to start in North America, counted across the 2 countries we report on there, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in North America. Retrieved 12 Nov 2026.
How much research is published on Menopause Treatment?
PubMed lists 28 papers on Menopause Treatment added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Pharmaceuticals reports in North America

See all

Related on women's health

See the topic